Which drugs does patent 8,518,421 protect, and when does it expire?
|Title:||Flashmelt oral dosage formulation|
|Abstract:||There is provided granules for the production of flash-melt pharmaceutical oral dosage forms. In addition to one or more medicaments, the granules are composed of an excipient combination consisting of a superdisintegrant, a dispersing agent, a distributing agent, and a binder and may also include other conventional ingredients such as sweetening and flavoring agents. The subject granules are advantageous in that they are stable and can be prepared without the aid of solvents and without the need for special environments or handling. Dosage forms, especially tablets, prepared therefrom on conventional equipment disintegrate in the mouth in under about twenty five seconds.|
|Inventor(s):||Kothari; Sanjeev H. (Princeton, NJ), Desai; Divyakant S. (West Windsor, NJ)|
|Assignee:||Bristol-Myers Squibb Company (Princeton, NJ)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form;|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|TABLET, ORALLY DISINTEGRATING;ORAL||021729-002||Jun 7, 2006||DISCN||No||No||8,518,421*PED||► Subscribe||Y|
|TABLET, ORALLY DISINTEGRATING;ORAL||021729-003||Jun 7, 2006||DISCN||No||No||8,518,421*PED||► Subscribe||Y|
|TABLET, ORALLY DISINTEGRATING;ORAL||021729-004||Jun 7, 2006||DISCN||Yes||No||8,518,421*PED||► Subscribe||Y|
|TABLET, ORALLY DISINTEGRATING;ORAL||021729-005||Jun 7, 2006||DISCN||Yes||No||8,518,421*PED||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.